Title: Study of Lipid profile in chronic kidney disease patients
Authors: Dr Sarita H Patel, Dr Milav Bhavsar, Dr Alok Parekh, Dr Rinku Bhanavadiya
DOI: https://dx.doi.org/10.18535/jmscr/v7i4.113
Abstract
Background: Chronic kidney disease (CKD) is associated with premature atherosclerosis and increased incidence of cardiovascular morbidity and mortality. Several factors contribute to atherogenesis and cardiovascular disease in patients with CKD. Notable among the CKD-induced risk factors are lipid disorders, oxidative stress, inflammation, physical inactivity, anemia, hypertension, vascular calcification, endothelial dysfunction, and depressed nitric oxide availability.
Objective: To assess the pattern of lipid profile in chronic kidney disease patients along with comparision of lipid profile in chronic kidney disease patients with diabetes mellitus and without diabetes mellitus.
Methods: A total of 50 patients of chronic kidney disease (CKD)of age group 20-70 year and 50 age and sex matched healthy controls were included in this study. Blood specimens were collected from both groups and measurement of the lipid prfile, FBS, PPBS, S.creatinine and blood urea was done and compare results with the study group.
Results: Total cholesterol and LDL was significantly raised in patients of CKD compared to controls The triglycerides were elevated. However, the statistical analysis showed that it was not significant. There was statistically significant variation found in triglyceride, VLDL and HDL when compared with the comorbid conditions of hypertension.
Conclusion: There is significant amount of dyslipidemia is found in patients of CKD. so treatment of dyslipidemia will reduce mortality in CKD patients.
Keywords: CKD, lipid Profile, Hypertension, Diabetes mellitus.
References
- Lidner A, Charra B, Sherrard D. Accelerated atherosclerosis in prolonged Maintainance hemodialysis. N Engl J Med 1974;290:697-701.
- Tetsuo Shoji, Eiji Ishimura, Masaaki Inaba, Tsutomu Tabata, yoshiki Nishizawa. Atherogenic Lipoproteins in End-stage renal disease. Am J kidney dis 2001;38:S30-S33
- Foley RN, Parfrey PS, and Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32: S112–S119, 1998
- David CW,Ravinder Oxidation of LDL by mesangial cells may promote glomerular injury. Kidney Int 1994;45: 1628-36
- Vaziri ND, Sato T, Liang K. Molecular mechanisms of altered cholesterol metabolism in focal glomerulosclerosis. Kidney Int 2003;63:1756-63.
- Abrass Cellular lipid metabolism and the role of lipids in progressive renal disease. Am J Nephrol 2004; 24:46-53.
- .Attman PO, Samuelsson O, and Alaupovic P. Lipoprotein metabolism and renal failure. Am J Kidney Dis 21: 573–592, 1993
- Gerald appel, Jordan J Cohen, John T Harrington, Cheryl J Zusman. Lipid abnormalities in renal disease. Kidney int 1991;39:169-183
- Thomas Quaschning, Vera Krane, Thomas Metzger, Christoph Wanner. Abnormalities in uremic Lipoprotein Metabolism and it’s impact on cardiovascular disease. Am J kidney dis 2001;38:S14-S19
- CM Chan. Hyperlipidemia in chronic kidney Ann AcadMed Singapore 2005;35:31-35
- Nayak KC, Saini MS, Singh VB, Verma SK, Tanwar RS, Charanjeet Carotid artery intima - media thickness and its relation with lipid profile in non-diabetic uremic patients. Indian J Nephrol 2006;16:170-3
- Sharma BK, Jindal SK, Rana DS, Gupta B, Kumar Absence of hyperlipidemia in patients of chronic renal failure in Chandigarh.Ind.J.Med. Res 1980; 72:461-64.